Fingerprint
Dive into the research topics of 'TATTON: a multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically